Anna Rowe

1.8k total citations
9 papers, 116 citations indexed

About

Anna Rowe is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Anna Rowe has authored 9 papers receiving a total of 116 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hepatology, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Infectious Diseases. Recurrent topics in Anna Rowe's work include Liver Diseases and Immunity (2 papers), Maternal and fetal healthcare (1 paper) and Liver Disease and Transplantation (1 paper). Anna Rowe is often cited by papers focused on Liver Diseases and Immunity (2 papers), Maternal and fetal healthcare (1 paper) and Liver Disease and Transplantation (1 paper). Anna Rowe collaborates with scholars based in United Kingdom, United States and France. Anna Rowe's co-authors include Peter Stevens, Phil Richardson, Kevin Jones, Chris Evans, Chris J. Weston, Amanda Kirkham, David Adams, Amisha Desai, Gideon M. Hirschfield and Margaret Corrigan and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Anna Rowe

8 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Rowe United Kingdom 4 63 44 39 21 21 9 116
Lydia T. Komarnicky-Kocher United States 2 19 0.3× 116 2.6× 16 0.4× 11 0.5× 5 198
Elaine Walklet United Kingdom 7 3 0.0× 26 0.6× 27 0.7× 7 0.3× 14 126
Gillian Berry United States 2 3 0.0× 30 0.7× 38 1.0× 4 0.2× 1 0.0× 2 102
Michael M. Morgan United States 6 3 0.0× 23 0.5× 52 1.3× 3 0.1× 11 116
Katerina A.B. Gawronski United States 4 14 0.3× 16 0.4× 4 0.2× 36 1.7× 5 143
Marta López-Gómez Spain 6 5 0.1× 73 1.9× 16 0.8× 52 2.5× 13 165
Silvia Pirarba Italy 6 10 0.2× 57 1.5× 50 2.4× 8 303
Jason Bouziotis Belgium 6 22 0.5× 52 1.3× 5 0.2× 2 0.1× 19 141
Adam Allgood United States 5 8 0.2× 43 1.1× 78 3.7× 9 0.4× 5 110
Rachel Evans United Kingdom 5 14 0.3× 41 1.1× 72 3.4× 18 119

Countries citing papers authored by Anna Rowe

Since Specialization
Citations

This map shows the geographic impact of Anna Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rowe more than expected).

Fields of papers citing papers by Anna Rowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rowe. The network helps show where Anna Rowe may publish in the future.

Co-authorship network of co-authors of Anna Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rowe. A scholar is included among the top collaborators of Anna Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rowe. Anna Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
3.
Chen, Yung‐Yi, Anna Rowe, Victoria Homer, et al.. (2022). Monoclonal antibody BTT1023 targeting vascular adhesion protein 1 for treating primary sclerosing cholangitis: BUTEO single-arm Phase II trial. SHILAP Revista de lepidopterología. 9(1). 1–54. 3 indexed citations
4.
Retzer, Ameeta, Olalekan Lee Aiyegbusi, Anna Rowe, et al.. (2022). The value of patient-reported outcomes in early-phase clinical trials. Nature Medicine. 28(1). 18–20. 4 indexed citations
6.
Veenith, Tonny, Benjamin A. Fisher, Daniel Slade, et al.. (2021). CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults. BMJ Open. 11(11). e050202–e050202. 3 indexed citations
8.
Skarbinski, Jacek, Peter Ouma, Louise Causer, et al.. (2007). Introduction of malaria rapid diagnostic tests, new guidelines, and artemether-lumefantrine in Kenya: A cluster randomized trial. American Journal of Tropical Medicine and Hygiene. 77. 97–97. 2 indexed citations
9.
Richardson, Phil, Kevin Jones, Chris Evans, Peter Stevens, & Anna Rowe. (2007). Exploratory RCT of art therapy as an adjunctive treatment in schizophrenia. Journal of Mental Health. 16(4). 483–491. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026